Attached files
| file | filename |
|---|---|
| EX-99 - EX-99 - HUMAN GENOME SCIENCES INC | d307118dex99.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 27, 2012
| HUMAN GENOME SCIENCES, INC. |
(Exact name of registrant as specified in its charter)
| Delaware | 001-14169 | 22-3178468 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| 14200 Shady Grove Road, Rockville, Maryland 20850-7464 |
(Address of principal executive offices, including zip code)
Registrant’s telephone number, including area code: (301) 309-8504
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Section 2 — Financial Information
Item 2.02. Results of Operations and Financial Condition.
On February 27, 2012, Human Genome Sciences, Inc. issued a press release announcing its financial results for the quarter and full year ended December 30, 2011. A copy of the release is furnished as Exhibit 99 to this Current Report on Form 8-K.
Section 9 — Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| 99 | Press Release dated February 27, 2012 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| HUMAN GENOME SCIENCES, INC. | ||||
| By: | /s/ James H. Davis, Ph.D. | |||
| Name: | James H. Davis, Ph.D. | |||
| Title: | Executive Vice President, General Counsel and Secretary | |||
Date: February 27, 2012
INDEX TO EXHIBITS
| Exhibit No. |
Description | |
| Exhibit 99 | Press Release dated February 27, 2012. | |